Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Anti-neurofascin antibody in patients with combined central and peripheral demyelination.

Kawamura N, Yamasaki R, Yonekawa T, Matsushita T, Kusunoki S, Nagayama S, Fukuda Y, Ogata H, Matsuse D, Murai H, Kira J.

Neurology. 2013 Aug 20;81(8):714-22. doi: 10.1212/WNL.0b013e3182a1aa9c. Epub 2013 Jul 24.

PMID:
23884033
2.

[Neurofascin: a novel target for combined central and peripheral demyelination].

Kawamura N.

Rinsho Shinkeigaku. 2014;54(12):978-80. doi: 10.5692/clinicalneurol.54.978. Review. Japanese.

PMID:
25672685
3.

Nodal proteins are target antigens in Guillain-Barré syndrome.

Devaux JJ, Odaka M, Yuki N.

J Peripher Nerv Syst. 2012 Mar;17(1):62-71. doi: 10.1111/j.1529-8027.2012.00372.x.

PMID:
22462667
4.

Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.

Koike H, Kadoya M, Kaida KI, Ikeda S, Kawagashira Y, Iijima M, Kato D, Ogata H, Yamasaki R, Matsukawa N, Kira JI, Katsuno M, Sobue G.

J Neurol Neurosurg Psychiatry. 2017 Jun;88(6):465-473. doi: 10.1136/jnnp-2016-314895. Epub 2017 Jan 10.

PMID:
28073817
5.

A case of anti-neurofascin 155 antibody-positive combined central and peripheral demyelination successfully treated with plasma exchange.

Shimizu M, Koda T, Nakatsuji Y, Ogata H, Kira JI, Mochizuki H.

Rinsho Shinkeigaku. 2017 Jan 31;57(1):41-44. doi: 10.5692/clinicalneurol.cn-000964. Epub 2016 Dec 23.

PMID:
28025411
6.

Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.

Vural A, Göçmen R, Kurne AT, Oğuz KK, Temuçin ÇM, Tan E, Karabudak R, Meinl E, Erdem Özdamar S.

Can J Neurol Sci. 2016 Jan;43(1):149-56. doi: 10.1017/cjn.2015.238. Epub 2015 Aug 14.

PMID:
26271726
7.

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

Devaux JJ, Miura Y, Fukami Y, Inoue T, Manso C, Belghazi M, Sekiguchi K, Kokubun N, Ichikawa H, Wong AH, Yuki N.

Neurology. 2016 Mar 1;86(9):800-7. doi: 10.1212/WNL.0000000000002418. Epub 2016 Feb 3.

8.

Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis.

Yan W, Nguyen T, Yuki N, Ji Q, Yiannikas C, Pollard JD, Mathey EK.

J Neuroimmunol. 2014 Dec 15;277(1-2):13-7. doi: 10.1016/j.jneuroim.2014.09.012. Epub 2014 Sep 18.

PMID:
25262157
9.

Neurofascin as a target for autoantibodies in peripheral neuropathies.

Ng JK, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T, Linington C, Odaka M, Tackenberg B, Prüss H, Schwab JM, Harms L, Harms H, Sommer C, Rasband MN, Eshed-Eisenbach Y, Peles E, Hohlfeld R, Yuki N, Dornmair K, Meinl E.

Neurology. 2012 Dec 4;79(23):2241-8. doi: 10.1212/WNL.0b013e31827689ad. Epub 2012 Oct 24.

11.

Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.

Querol L, Nogales-Gadea G, Rojas-Garcia R, Diaz-Manera J, Pardo J, Ortega-Moreno A, Sedano MJ, Gallardo E, Berciano J, Blesa R, Dalmau J, Illa I.

Neurology. 2014 Mar 11;82(10):879-86. doi: 10.1212/WNL.0000000000000205. Epub 2014 Feb 12.

13.

A case of a 17-year-old male with neurofascin-155 antibody-positive chronic inflammatory demyelinating polyradiculoneuropathy presenting with tremor and ataxia.

Itaya K, Inoue M, Iizuka N, Shimizu Y, Yuki N, Ichikawa H.

Rinsho Shinkeigaku. 2016 Sep 29;56(9):633-6. doi: 10.5692/clinicalneurol.cn-000853. Epub 2016 Aug 31.

PMID:
27580761
15.

Autoantibodies in neuroimmunological diseases; relevance of fine specificity.

Kusunoki S.

Exp Neurol. 2013 Dec;250:219-20. doi: 10.1016/j.expneurol.2013.10.009. Epub 2013 Oct 10.

PMID:
24120752
16.

Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.

Cortese A, Franciotta D, Alfonsi E, Visigalli N, Zardini E, Diamanti L, Prunetti P, Osera C, Gastaldi M, Berzero G, Pichiecchio A, Piccolo G, Lozza A, Piscosquito G, Salsano E, Ceroni M, Moglia A, Bono G, Pareyson D, Marchioni E.

J Neurol Sci. 2016 Apr 15;363:182-7. doi: 10.1016/j.jns.2016.02.022. Epub 2016 Feb 10.

PMID:
27000248
17.
18.

Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy.

Doppler K, Appeltshauser L, Krämer HH, Ng JK, Meinl E, Villmann C, Brophy P, Dib-Hajj SD, Waxman SG, Weishaupt A, Sommer C.

PLoS One. 2015 Jul 28;10(7):e0134274. doi: 10.1371/journal.pone.0134274. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0137443.

19.

Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.

Doppler K, Appeltshauser L, Wilhelmi K, Villmann C, Dib-Hajj SD, Waxman SG, Mäurer M, Weishaupt A, Sommer C.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):720-8. doi: 10.1136/jnnp-2014-309916. Epub 2015 Feb 18.

PMID:
25694474
20.

Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.

Khalili-Shirazi A, Atkinson P, Gregson N, Hughes RA.

J Neuroimmunol. 1993 Jul;46(1-2):245-51.

PMID:
7689591

Supplemental Content

Support Center